CNO Financial Group Inc (CNO) Performance and Fundamentals Dashboard tells a completely different story

With 1.08 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.79 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $27.53 whereas the lowest price it dropped to was $26.68. The 52-week range on CNO shows that it touched its highest point at $28.39 and its lowest point at $19.95 during that stretch. It currently has a 1-year price target of $27.60. With its current market cap of 3.01 billion, CNO has annualized dividend of $0.63 while the current yield stands at 2.34%. Beta for the stock currently stands at 1.06.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CNO was up-trending over the past week, with a rise of 0.79%, but this was up by 1.02% over a month. Three-month performance surged to 9.10% while six-month performance rose 9.59%. The stock gained 5.54% in the past year, while it has lost -3.76% so far this year. A look at the trailing 12-month EPS for CNO yields 2.41 with Next year EPS estimates of 3.41. For the next quarter, that number is 0.71. This implies an EPS growth rate of 2.02% for this year and 8.07% for next year.

Float and Shares Shorts:

At present, 109.36 million CNO shares are outstanding with a float of 109.22 million shares on hand for trading. On Jan 11, 2024, short shares totaled 2.13 million, which was 1.90% higher than short shares on Dec 14, 2023. In addition to Mr. Gary Chandru Bhojwani as the firm’s CEO & Director, Mr. Paul Harrington McDonough serves as its CFO & Executive VP.

Institutional Ownership:

Through their ownership of 98.35% of CNO’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CNO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CNO analysts setting a high price target of $30.00 and a low target of $26.00, the average target price over the next 12 months is $28.20. Based on these targets, CNO could surge 11.73% to reach the target high and fall by -3.17% to reach the target low. Reaching the average price target will result in a growth of 5.03% from current levels.

Summary of Insider Activity:

Insiders traded CNO stock several times over the past three months with 0 Buys and 2 Sells. In these transactions, 0 shares were bought while 11,479 shares were sold. The number of buy transactions has increased to 48 while that of sell transactions has risen to 64 over the past year. The total number of shares bought during that period was 2,022,911 while 736,804 shares were sold.